John T Curnutte

Title: Innovations by John T. Curnutte

Introduction

John T. Curnutte is a notable inventor based in Tustin, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidotes and treatments for various medical conditions. With a total of two patents to his name, Curnutte's work has the potential to impact patient care significantly.

Latest Patents

Curnutte's latest patents include innovative solutions in the medical field. One of his patents focuses on "Antidotes to Factor XA Inhibitors." This invention relates to antidotes for anticoagulants that target factor Xa. The antidotes are designed as factor Xa protein derivatives that bind to the factor Xa inhibitors, effectively neutralizing them without assembling into the prothrombinase complex. Notably, these derivatives may lack or have reduced intrinsic coagulant activity. Another significant patent involves "Methods for Treating Lymphoma." This patent provides compositions and methods for treating lymphoma, specifically T-cell lymphoma and follicular lymphoma, in human patients. The methods entail administering an effective amount of cerdulatinib to the patient.

Career Highlights

Curnutte is currently associated with Alexion Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving treatment options for patients with serious health conditions.

Collaborations

Curnutte has collaborated with several professionals in his field, including Pamela B. Conley and Genmin Lu. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

John T. Curnutte's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving medical treatments. His work has the potential to make a significant difference in patient care and treatment outcomes.